Phenobarbital suppresses vitamin D3 25-hydroxylase expression: A potential new mechanism for drug-induced osteomalacia
- 1 June 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 357 (3) , 603-607
- https://doi.org/10.1016/j.bbrc.2007.03.177
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylasesSteroids, 2006
- Isolation and properties of the CYP2D25 promoter: Transcriptional regulation by vitamin D3 metabolitesBiochemical and Biophysical Research Communications, 2006
- Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalaciaJournal of Clinical Investigation, 2006
- Intestinal and Hepatic CYP3A4 Catalyze Hydroxylation of 1α,25-Dihydroxyvitamin D3: Implications for Drug-Induced OsteomalaciaMolecular Pharmacology, 2006
- Enzymes involved in the activation and inactivation of vitamin DTrends in Biochemical Sciences, 2004
- Eight cytochrome P450s catalyze vitamin D metabolismFrontiers in Bioscience-Landmark, 2004
- The effects of anticonvulsant drugs on vitamin D3-activating cytochrome P-450-linked monooxygenase systemsThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Inhibition of rat liver calciferol 25-hydroxylase activity with anticonvulsant drugsLife Sciences, 1977
- Phenobarbital-Induced Alterations in Vitamin D MetabolismJournal of Clinical Investigation, 1972
- Osteomalacia with Long-term Anticonvulsant Therapy in EpilepsyBMJ, 1970